2018-12-20
Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer"
Publication
Publication
New England Journal of Medicine
,
Volume 379
-
Issue 25
p. 2481
| Additional Metadata | |
|---|---|
| Persistent URL | dx.doi.org/10.1056/NEJMc1814750, hdl.handle.net/1765/113488 |
| Journal | New England Journal of Medicine |
| Citation |
Coebergh van den Braak, R.R.J, Martens, J.W.M, & IJzermans, J.N.M. (2018). Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer". New England Journal of Medicine, 379(25). doi:10.1056/NEJMc1814750
|